Acne face wash with 4% foaming benzoyl peroxide
The CeraVe Acne Foaming Cream Cleanser is a medicated acne face wash that helps to clear breakouts and keep skin hydrated. The benzoyl peroxide in the formula kills acne-causing bacteria, while ceramides help to lock in moisture. The non-comedogenic cleanser is also oil-free, sulfate-free, and fragrance-free.
Suppose you are not using an effective acne product in your anti-acne regimen. In that case, it may result negatively because the right acne cleanser can act as an over-the-counter and prescription-based treatment.
The formula used in CeraVe Acne Foaming Cream Cleanser is made to dissolve excess oil and dirt thoroughly without leaving acne marks behind with the help of 4% benzoyl peroxide. Moreover, other ingredients, such as hyaluronic acid and niacinamide, are also present to rescue your skin by helping retain the moisture and providing soothing benefits.
Developed by dermatologists, this cleanser reduces the formation of new acne blemishes and clears the skin from acne. The 3-essential ceramides help protect your skin’s natural barrier, leaving your skin soft and smooth without raising skin dryness.
Ingredients
Active Ingredient: Benzoyl Peroxide 4%
Inactive Ingredients: Water, Glycerin, Lauryl Glucoside, Aloe Barbadensis Leaf Juice, Caprylyl Glycol, Phenoxyethanol, Coco-Glucoside, Sodium Hydroxide, Disodium EDTA.
How to use
Wet face and massage cleanser into skin. Rinse thoroughly. Use morning and evening. For best results, pair with a CeraVe acne treatment product.
Warning
For external use only. When using this product avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water. Stop use and ask a doctor if excessive skin irritation develops or increases. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.
CeraVe acne foaming cream cleanser price in Pakistan
CeraVe acne foaming cream cleanser is available online at BuyUs.pk at the price of PKR 5,250/- (100ml).
Reviews
There are no reviews yet.